BEDINI, ANNALIDA
 Distribuzione geografica
Continente #
NA - Nord America 11.802
EU - Europa 8.626
AS - Asia 4.007
SA - Sud America 339
AF - Africa 68
Continente sconosciuto - Info sul continente non disponibili 22
OC - Oceania 11
AN - Antartide 1
Totale 24.876
Nazione #
US - Stati Uniti d'America 11.670
GB - Regno Unito 2.131
CN - Cina 2.019
NL - Olanda 1.971
IT - Italia 1.086
SG - Singapore 1.058
UA - Ucraina 896
SE - Svezia 529
RU - Federazione Russa 507
FI - Finlandia 428
DE - Germania 407
TR - Turchia 370
BR - Brasile 249
FR - Francia 217
IE - Irlanda 192
VN - Vietnam 172
IN - India 104
CA - Canada 94
HK - Hong Kong 47
BE - Belgio 46
PL - Polonia 38
ES - Italia 37
AR - Argentina 35
BD - Bangladesh 35
JP - Giappone 31
KR - Corea 31
AT - Austria 23
MX - Messico 23
RO - Romania 21
IQ - Iraq 19
EU - Europa 18
ID - Indonesia 18
EG - Egitto 16
ZA - Sudafrica 16
KE - Kenya 15
AE - Emirati Arabi Uniti 12
AL - Albania 12
PK - Pakistan 12
CH - Svizzera 11
LT - Lituania 11
PT - Portogallo 11
SA - Arabia Saudita 11
CL - Cile 9
CO - Colombia 9
PE - Perù 9
AU - Australia 8
EC - Ecuador 7
IL - Israele 7
KZ - Kazakistan 7
PY - Paraguay 7
UZ - Uzbekistan 7
VE - Venezuela 7
DK - Danimarca 6
GR - Grecia 6
IR - Iran 6
MA - Marocco 6
PH - Filippine 6
EE - Estonia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AZ - Azerbaigian 4
CZ - Repubblica Ceca 4
JO - Giordania 4
MY - Malesia 4
NP - Nepal 4
SI - Slovenia 4
TG - Togo 4
AM - Armenia 3
BG - Bulgaria 3
BZ - Belize 3
HU - Ungheria 3
JM - Giamaica 3
LU - Lussemburgo 3
MD - Moldavia 3
OM - Oman 3
SK - Slovacchia (Repubblica Slovacca) 3
TW - Taiwan 3
UY - Uruguay 3
AO - Angola 2
BB - Barbados 2
BO - Bolivia 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
GU - Guam 2
HN - Honduras 2
IS - Islanda 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
RS - Serbia 2
SM - San Marino 2
TN - Tunisia 2
BF - Burkina Faso 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DZ - Algeria 1
ET - Etiopia 1
FK - Isole Falkland (Malvinas) 1
GA - Gabon 1
GE - Georgia 1
GS - Georgia del Sud e Isole Sandwich Australi 1
GT - Guatemala 1
Totale 24.862
Città #
Amsterdam 1.944
Southend 1.893
Dallas 1.194
Woodbridge 1.169
Fairfield 968
Ashburn 921
Houston 759
Jacksonville 710
Ann Arbor 677
Chandler 588
Singapore 542
San Jose 455
Cambridge 446
Wilmington 394
Seattle 382
Nanjing 352
Beijing 308
Urbino 275
Izmir 258
Helsinki 194
Dublin 188
Boardman 187
Los Angeles 178
Chicago 153
Nanchang 153
New York 150
San Mateo 113
Princeton 106
Lauterbourg 101
Düsseldorf 86
Shenyang 83
Munich 81
Hebei 78
Changsha 77
Tianjin 76
Salt Lake City 69
Des Moines 66
Ho Chi Minh City 65
Istanbul 65
Jiaxing 56
Council Bluffs 50
Brussels 45
Kunming 43
Moscow 42
London 41
Santa Clara 41
Shanghai 41
Elk Grove Village 39
Hong Kong 39
Jinan 38
Tampa 38
Velikiy Novgorod 38
Hanoi 37
Toronto 37
Turku 36
Bremen 35
Guangzhou 35
San Francisco 35
Hangzhou 34
Buffalo 32
Nuremberg 32
Orem 32
Venice 31
Frankfurt am Main 30
Warsaw 30
San Diego 28
São Paulo 27
Rome 26
Seongnam 24
Zhengzhou 24
Chennai 23
Montreal 23
Ningbo 22
Stockholm 22
Bellaria-Igea Marina 21
Mülheim 20
Tokyo 20
Haikou 19
Milan 19
Sterling 19
Denver 18
Dulles 18
Wuppertal 18
Changchun 17
Tavullia 17
Lancaster 16
Manchester 16
Phoenix 16
Parma 15
The Dalles 15
Bologna 14
Boston 14
Brooklyn 14
Lanzhou 14
Poplar 14
Augusta 13
Norwalk 13
Atlanta 12
Johannesburg 12
Mumbai 12
Totale 18.126
Nome #
1-Aminocyclopropane-1-carboxylic acid derivatives as ligands at the glicine-site of the NMDA receptor. 3.172
Industrial and academic approaches to the search for alternative melatonin receptor ligands: An historical survey. 704
1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID DERIVATIVES AS LIGANDS AT THE GLYCINE-BINDING SITE OF THE N-METHYL-D-ASPARTATE RECEPTOR 429
Iridium-Catalyzed Direct Synthesis of Tryptamine Derivatives from Indoles: Exploiting N-Protected β-Amino Alcohols as Alkylating Agents 389
1-Aminocyclopropane-1-carboxylic acid derivatives: Synthesis and NMDA receptor complex binding affinity study. 328
1-Amminocyclopropane-1-Carboxylic Acid Derivatives: A New, General Synthesis and NMDA Receptor Complex Binding Affiniy Study 326
An improved synthesis of cis-4-phenyl-2-propionamidotetralin (4-P-PDOT): a selective MT2 melatonin receptor antagonist. 320
Therapeutic uses of melatonin and melatonin derivatives: a patent review (2012-2014) 320
Towards the development of 5-HT7 ligands combining serotonin-like and arylpiperazine moieties 302
Synthesis and Configuration Determination of All Enantiopure Stereoisomers of the Melatonin Receptor Ligand 4-Phenyl-2-propionamidotetralin using an Expedient Optical Resolution of 4-Phenyl-2-tetralone 299
Synthesis of Tryptamine Derivatives via a Direct, One-Pot Reductive Alkylation of Indoles 296
Design, synthesis and biological activity of hydrogen peroxide responsive arylboronate melatonin hybrids 294
(E)-3-(2-(N-phenylcarbamoyl)vinyl)pyrrole-2-carboxylic acid derivatives. A novel class of glycine site antagonists. 275
3-(2-Carbamoylvinyl)-4,5-dimethylpyrrole-2-carboxylic acids as ligands at the NMDA glycine-binding site: a study on the 2-carbamoylvinyl chain modification 274
Synthesis and Characterization of New Bivalent Agents as Melatonin- and Histamine H3-Ligands 274
Synthesis and Biological Activity of new melatonin dimeric derivatives. 272
Antidepressant-like activity and cardioprotective effects of fatty acid amide hydrolase inhibitor URB694 in socially stressed Wistar Kyoto rats 271
Tricyclic Alkylamides as Melatonin Receptor Ligands with Antagonist or Inverse Agonist Activity 270
Tetrahydroquinoline Ring as a Versatile Bioisostere of Tetralin for Melatonin Receptor Ligands 270
Highly Potent and Selective MT2 Melatonin Receptor Full Agonists from Conformational Analysis of 1-Benzyl-2-acylaminomethyl-tetrahydroquinolines 269
4,5-Dihydroisoxazole and 4,5-dihydro-1,2,4-oxadiazole derivatives from cycloaddition reactions of nitrile oxides to alkyl N-(diphenylmethylene)-α ,β -dehydroamino acids 268
Direct, One-Pot Reductive Alkylation of Anilines with Functionalized Acetals Mediated by Triethylsilane and TFA. Straightforward Route for Unsymmetrically Substituted Ethylenediamine 264
An improved route to cycloalka[b]pyrrole 2-carboxylates 262
Selective Melatonin MT2 receptor ligands relieve neuropathic pain through modulation of brainstem descending antinociceptive pathways 259
Identification of Bivalent Ligands with Melatonin Receptor Agonist and Fatty Acid Amide Hydrolase (FAAH) Inhibitory Activity That Exhibit Ocular Hypotensive Effect in the Rabbit 257
2-[N-Acylamino(C1-C3)alkyl]indoles as MT1 melatonin receptor partial agonists, antagonists, and putative inverse agonists 240
Application of a non-electrophysiological method to study binding affinity and efficacy of glicine analogs to the glicine site of the NMDA receptor-ion channel complex. 233
2,3-Dehydroamino acid derivatives as intermediates in the synthesis of heterocyclic compounds. 227
The rationale for the development of melatonin receptor ligands 223
Diastereo- and enantioselective hydrogenation of a challenging enamide derived from 4-phenyl-2-tetralone: an appealing shortcut towards enantiopure cis-2-aminotetraline derivatives 223
2-Arylmelatonin analogues: Probing the 2-phenyl binding pocket of melatonin MT1 and MT2 receptors 222
N-(Substituted-anilinoethyl)acylamides: Design, Synthesis and Pharmacological Characterization of a New Class of Melatonin Receptor Ligands 221
N-(Anilinoethyl)amides: design and synthesis of metabolically stable, selective melatonin receptor ligands. 219
Design and synthesis of N-[3,3-diphenyl-propenyl]alkanamides as a novel class of potent MT2-selective Melatonin receptor ligands 218
(E)-3-[2-(Carbamoylvinyl)]pyrrol-2-carboxylic acid derivatives: A novel Class of glycine site Antagonists. 218
Bivalent Ligand Approach on N-[2-[(3-methoxyphenyl)methylamino]ethyl]acetamide. Synthesis, Binding Affinity and Intrinsic Acivity for MT(1) and MT(2) melatonin Receptors. 217
Toward the Definition of Stereochemical Requirements for MT(2)-Selective Antagonists and Partial Agonists by Studying 4-Phenyl-2-propionamidotetralin Derivatives 217
Melatonin MT1 and MT2 Receptors Exhibit Distinct Effects in the Modulation of Body Temperature across the Light/Dark Cycle 217
Pharmacokinetic and pharmacodynamic evaluation of ramelteon : an insomnia therapy 216
Synthetic Melatonin Receptor Ligands 215
Cardioprotective effects of fatty acid amide hydrolase inhibitor URB694, in a rodent model of trait anxiety 214
Differentiation between isomeric 1-aminocyclopropane-1-carboxylic acid derivatives by means of chemical ionisation and mass selected collision induced dissociation 210
N-acetiltriptamine 2,5-sostituite: sintesi e valutazione dell’attività biologica per i recettori melatoninergici MT1 e MT2 210
N-Acyl-5- and -2,5-substituted tryptamines: synthesis, activity and affinity for human mt1 and MT2 melatonin receptors 208
Plant-derived phenolic compounds prevent the DNA single-strand breakage and cytotoxicity induced by tert-butylhydroperoxide via an iron-chelating mechanism. 207
Promotion of non-rapid eye movement sleep and activation of reticular thalamic neurons by a novel MT2 melatonin receptor ligand 207
Synthesis, Enantiomeric Resolution and Structure-Activity Relationship Study for a Series of 10,11-Dihydro-5H-dibenzo[a,d]cycloheptene MT2 Receptor Antagonists. 205
Antiproliferative and pro-apoptotic activity of melatonin analogues on melanoma and breast cancer cells 205
Homology models of melatonin receptors: challenges and recent advances 199
MELATONIN RECEPTOR AGONISTS: SAR AND APPLICATIONS TO THE TREATMENT OF SLEEP-WAKE DISORDERS 198
Alchilammidi tricicliche: legandi selettivi dei recettori melatoninergici MT1 e MT2 198
SYNTHESIS, BINDING AFFINITY FOR THE MELATONIN RECEPTOR, AND EVALUATION OF THE BIOLOGICAL ACTIVITY OF NEW INDOLE-BASED MELATONIN ANALOGUES. 196
Substituent effects on 1,3-dipolar cycloadditions to some 1,1-diphenyl-2-aza-1,3-butadiene derivatives 188
Application of 3D-QSAR in the Rational Design of Receptor Ligands and Enzyme Inhibitors 188
A novel melatonin partial agonist with sleep-promoting properties 186
Synthesis and conformational study of 3,4-carbocyclic bridged indole melatonin and serotonin analogues 183
THREE-DIMENSIONAL QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP STUDIES ON SELECTED MT1 AND MT2 MELATONIN RECEPTOR LIGANDS: REQUIREMENTS FOR SUBTYPE SELECTIVITY AND INTRINSIC ACTIVITY MODULATION 182
Strategies leading to MT2 selective melatonin receptor antagonists 181
Anxiolytic effects of the melatonin MT2 receptor partial agonist UCM765: Comparison with melatonin and diazepam 181
ANTIMETASTATIC ACTION OF A NEW ANALOG OF DACARBAZINE IN MICE BEARING LEWIS LUNG CARCINOMA 178
Reactions of 3-Carbomethoxy-2-aza-1,3-Butadiene Derivatives with Dienophiles 177
2-5-Disubstituted tryptamines a selective serotonin 5HT6 receptor agonists. 176
Recent advances in the development of melatonin MT1 and MT2 receptor agonists 175
Synthesis and biological evaluation of 6-bromo-6-substituted penicillanic acid derivatives as beta-lactamase inhibitors. 174
Progettazione e Sintesi di nuovi ligandi dei recettori MT1 e MT2 della melatonina a struttura difenilalchilammidica. 174
Strategies leading to MT2 selective melatonin receptor antagonists 173
Melatonin receptor agonists: new options for insomnia and depression treatment 172
Synthesis, antioxidant activity and structure-activity relationships for a new series of 2-(N-acylaminoethyl)indoles with melatonin-like cytoprotective activity 171
Melatonin, non-selective MT1/MT2 and selective MT2 receptor agonists: differential effects on the 24-hr vigilance states 169
Analysis of structure-activity relationships for MT2 selective antagonists by melatonin MT1 and MT2 receptor models 166
Short synthesis of tryptophan and β -carboline derivatives by reaction of indoles with N-(diphenylmethylene)-α ,β -didehydroamino acid esters 164
Antioxidant and cytoprotective activity of indole derivatives related to melatonin, 163
Synthesis, Pharmacological Characterization and QSAR Studies on 2-Substituted Indole Melatonin Receptor Ligands 162
Antioxidant and cytoprotective effect of indole derivatives related to melatonin 161
A novel melatonin partial agonist with sleep promoting properties and anti-anxiety effects. 159
A novel melatonin partial agonist with sleep-promoting properties. 157
N-(anilinoethyl)acylamides: new melatonin receptor ligands with sleep inducing properties. 157
MT2 selective melatonin receptor antagonists. Design and structure activity relationships 156
Indole-based analogs of melatonin: in vitro antioxidant and cytoprotective activities 154
N-(Anilinoethyl)amide Melatonergic Ligands with Improved Water Solubility and Metabolic Stability 154
Synthesis of new 6-bromopenicillanic acid derivatives as potential β-lactamase inhibitors. 147
Synthesis of new C-6 alkylidene penicillin derivatives as beta-lactamase inhibitors 142
MT1-Selective Melatonin Receptor Ligands: Synthesis, Pharmacological Evaluation, and Molecular Dynamics Investigation of N-{[(3-O-Substituted)anilino]alkyl}amides 141
Correlation of the antimetastatic properties of aryltriazenes with their Electron Impact Ionization Mass Spectronomy 139
MT2 selective melatonin receptor antagonists: design and structure-activity relationships 139
Towards the development of mixed MT1-agonist/MT2-antagonist melatonin receptor ligands 139
Selective increase of Slow Wave Sleep (SWS) by a novel melatonin partial agonist 133
Analoghi della melatonina: effetto dei sostituenti sull’attività di derivati N-acetiltriptaminici. 131
Rapid and transient stimulation of intracellular reactive oxygen species by melatonin in normal tumor leukocytes, Toxicology and apllied Pharmacology, 239(1), 37-45 (2009) 130
Synthesis, binding and QSAR studies of new 2-substituted melatonergic agonists. 130
Chiral Recognition of Flexible Melatonin Receptor Ligands Induced by Conformational Equilibria 130
Binding and unbinding of potent melatonin receptor ligands: Mechanistic simulations and experimental evidence 129
In vitro metabolism of the melatonin MT2-receptor selective ligand UCM765 by rat, mouse and human liver substrates 129
INVESTIGATION OF SOME 2,3-DIDEHYDRO AMINOACIFS BY FAST ATOM BOMBARDMENT, CHEMICAL IONIZATION AND MASS-SELECTED COLLISION-INDUCED DISSOCIATION MASS SPECTROMETRY. 128
Novel melatonin ligands having antidepressant activity as well as sleep inducine properties 126
Chemical modification of NSC12 leads to a specific FGF-trap with antitumor activity in multiple myeloma 126
Synthesis of new 6-alkyliden penicillin derivatives as potential beta-lactamase inhibitors. 123
Selective increase of Slow Wave Sleep (SWS) by melatonin 2 receptors. 121
Advances on the Development of Subtype Selective Melatonin Ligands 120
In vitro evaluation of antioxidant activity for a series of 2-acylaminoethylindoles, PBA2004 114
Totale 23.845
Categoria #
all - tutte 78.536
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.536


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021599 0 0 0 0 0 0 0 0 0 225 255 119
2021/20221.284 128 145 125 165 23 35 57 62 86 72 31 355
2022/20231.850 209 122 56 207 163 405 7 165 296 56 122 42
2023/2024565 32 58 28 77 40 100 32 13 67 57 18 43
2024/20252.718 136 105 428 110 67 162 277 109 167 159 247 751
2025/20267.039 433 657 1.177 772 384 384 618 168 2.151 295 0 0
Totale 25.133